The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sanadze A.G.

Moscow Myasthenic Center of the City Clinical Hospital No. 51

Gilvanova O.V.

Moscow Myasthenic Center of the City Clinical Hospital No. 51

Myasthenia gravis and muscle atrophy

Authors:

Sanadze A.G., Gilvanova O.V.

More about the authors

Read: 11136 times


To cite this article:

Sanadze AG, Gilvanova OV. Myasthenia gravis and muscle atrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(2):79‑87. (In Russ.)
https://doi.org/10.17116/jnevro202112102179

Recommended articles:
Clinical and epidemiological characteristics of myasthenia in the Altai region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):198-202
New pathogenic treatments for myasthenia gravis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):31-38
Comparison of prognostic scales of myasthenic crisis after thymectomy in patients with myasthenia gravis. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):63-69
Robo­tic and thoracoscopic surgeries for ante­rior mediastinal neoplasms. Piro­gov Russian Journal of Surgery. 2025;(2):6-12

References:

  1. Osserman KE. Studies in Myasthenia Gravis. AMA Arch Int Med. 1958;102(1):72.  https://doi.org/10.1001/archinte.1958.00260190074008
  2. Kusin MI, Geht BM. Myasthenia. Moscow: Medicina; 1996. (In Russ.).
  3. Kasatkina LF, Sanadze AG, Gilvanova OV, Shherbakova NI. Two cases post-polio syndrome and myasthenia gravis. Nevrologicheskij zhurnal. 2003;8(1):37–41. (In Russ.).
  4. Sanadze AG. Myasthenia and myasthenic syndromes. Moscow: Litera; 2012. (In Russ.).
  5. Skeie GO, Romi F, Aarli JA, et al. Pathogenesis of Myositis and Myasthenia Associated with Titin and Ryanodine Receptor Antibodies. Ann NY Acad Sci. 2003;998(1):343–350.  https://doi.org/10.1196/annals.1254.039
  6. Somnier FE, Skeie GO, Aarli JA, Trojaborg W. EMG evidence of myopathy and the occurrence of titin autoantibodies in patients with myasthenia gravis. Eur J Neurol. 1999;6(5):555–563.  https://doi.org/10.1046/j.1468-1331.1999.650555.x
  7. Zouvelou V, Rentzos M, Toulas P, Evdokimidis I. MRI Evidence of Early Muscle Atrophy in MuSK Positive Myasthenia Gravis. J Neuroimaging. 2009;21(3):303–305.  https://doi.org/10.1111/j.1552-6569.2009.00456.x
  8. Zouvelou V, Rentzos M, Toulas P, Evdokimidis I. AchR-positive myasthenia gravis with MRI evidence of early muscle atrophy. J Clin Neurosci. 2012;19(6):918–919.  https://doi.org/10.1016/j.jocn.2011.09.022
  9. Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational Antibodies in Myasthenia Gravis. Arch Neurology. 2005;62(3):442.  https://doi.org/10.1001/archneur.62.3.442
  10. Benveniste O, Jacobson L, Farrugia ME, et al. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J Neuroimmunol. 2005;170(1–2):41–48.  https://doi.org/10.1016/j.jneuroim.2005.08.016
  11. Sanadze AG, Sidnev DV, Vetshev PS, Ippolitov LI. Titin, thymoma and myasthenia. Neyroimmunologiya. 2006;(3–4):23–26. (In Russ.).
  12. Vetshev PS, Sanadze AG, Sidnev DV, Zhivotov VA. Antibodies against titin in patients with thymome without myasthenia and thymome with myasthenia. Khirurgia. 2007;(6):42–48. (In Russ.).
  13. Aarli JA, Stefansson K, Martson L, Wollmann RL. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin ExpImmunol. 2008;82(2):284–288.  https://doi.org/10.1111/j.1365-2249.1990.tb05440.x
  14. Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol Today. 1996;17:163–164.  https://doi.org/10.1016/S0167-5699(96)90258-3
  15. Skeie GO. Skeletal muscle titin: physiology and pathophysiology. Cell Mol Life Sci. 2000;57(11):1570–1576. https://doi.org/10.1007/pl00000642
  16. Mygland A, Aarli JA, Matre R, Gilhus NE. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J Neurol, Neurosurg Psychiatry. 1994;57(7):843–846.  https://doi.org/10.1136/jnnp.57.7.843
  17. Sanadze AG, Sidnev DV, Galkina OI, et al. Myasthenic myopathy. S.S. Korsakov Journal of Neurology and Psychiatry = Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2007;107(9):11–16. (In Russ.).
  18. Vincent A, McConville J, Farrugia ME, et al. Antibodies in Myasthenia Gravis and Related Disorders. Ann NY Acad Sci. 2003;998(1):324–335.  https://doi.org/10.1196/annals.1254.036
  19. Evoli A. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain. 2003;126(10):2304–2311. https://doi.org/10.1093/brain/awg223
  20. Newsom-Davis J. Neuromuscular junction channelopathies: a brief overview. Acta Neurol Belg. 2005;105(4):181–186. 
  21. Sanders DB, El-Salem K, Massey JM, et al. Clinical aspects of MuSK antibody positive seronegative MG. Neurology. 2003;60(12):1978–1980. https://doi.org/10.1212/01.wnl.0000065882.63904.53
  22. Punga AR, Flink R, Askmark H, Stålberg EV. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody. Muscle Nerve. 2006;34(1):111–115.  https://doi.org/10.1002/mus.20515
  23. Welander L. Myopathia distalis tarda hereditaria. In: Kuhn E, ed. Progressive Muskeldystrophie Myotonie Myasthenie. Springer, Berlin: Heidelberg; 1966. https://doi.org/10.1007/978-3-642-92920-5_13
  24. Garibaldi M, Fionda L, Vanoli F, et al. Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients. Autoimmun Rev. 2020;19(4):102498. https://doi.org/10.1016/j.autrev.2020.102498

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.